The results are shown for a better orientation and to complement the statistical analysis, but a few trends were observed in the results, the most noticeable ones were the increase in B lymphocytes and the decrease in NK cells. These trends were present in all subgroups, regardless of the clinical status (conversion to CDMS or no conversion). However, a profound decrease in B lymphocytes and an increase in NK cells was observed between the study entry and the baseline results and of at least 30 days prior to initiation of interferon therapy (of at least 30 days after steroid administration).